How a Saudi start-up hopes to beat sickle cell disease with an AI-trained gene-editing biorobot

Saudi Arabia-based biotechnology company NanoPalm is developing a biorobot that uses a unique blend of artificial intelligence, nanotechnology, and gene therapy to find a solution for patients with sickle cell disease. (10.05.2024, The National)